Genzyme Corporation v. Sandoz Inc.
1:13-cv-01507
Overview
Parties
Defendant
Sandoz Inc. Operating Company
Represented By
2 Attorneys ListedPhillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Phillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Plaintiff
Sanofi-Aventis U.S. LLC Operating Company
Represented By
2 Attorneys ListedRatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
Barnes & Thornburg LLP
1000 N. West Street, Suite 1500, Wilmington, DE 19801
Genzyme Corporation NPE (Individual / Inventor)
Represented By
7 Attorneys ListedRatnerPrestia, P.C.
1007 Orange Street, Suite 205, P.O. Box 1596
Barnes & Thornburg LLP
1000 N. West Street, Suite 1500, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Genzyme Corporation v. Zydus Pharmaceuticals (USA) Inc.
Genzyme Corporation v. Teva Pharmaceuticals USA Inc.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
USRE42152
Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity
|
Filed: 1992-12-16
Issued: 2011-02-15
|
Expired (Term Ended)
+2185d PTA
Expires: 2018-12-10
|
|
|
US7897590
Methods to mobilize progenitor/stem cells
|
Filed: 2007-08-20
Issued: 2011-03-01
|
Expired (Term Ended)
Expires: 2024-11-16
|
|
|
US6987102
Methods to mobilize progenitor/stem cells
|
Filed: 2002-07-30
Issued: 2006-01-17
|
Expired (Term Ended)
+357d PTA
Expires: 2023-07-22
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+2185 days) / Cellect Scrutiny β Over 2185 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).